Teva's Board Seeks Base Pay Raise of as Much as 10% for Vigodman

Teva Pharmaceutical Industries Ltd.’s board asked shareholders to let it raise Chief Executive Officer Erez Vigodman’s annual base pay by as much as 10 percent for the foreseeable future.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.